Cargando…
Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis
BACKGROUND: Observational studies and previous Mendelian randomization (MR) studies have shown that genetically low 25-hydroxyvitamin D (25OHD) levels are associated with a high susceptibility to multiple sclerosis (MS). The present MR study aims to update the causal estimates for the effects of 25O...
Autor principal: | Wang, Renxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722044/ https://www.ncbi.nlm.nih.gov/pubmed/34980161 http://dx.doi.org/10.1186/s12967-021-03205-6 |
Ejemplares similares
-
Genetic Variants, Serum 25-Hydroxyvitamin D Levels, and Sarcopenia: A Mendelian Randomization Analysis
por: Sha, Tingting, et al.
Publicado: (2023) -
Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies
por: Lawler, Thomas, et al.
Publicado: (2023) -
The causal effect of serum 25‐hydroxyvitamin D levels on epilepsy: A two‐sample Mendelian randomization study
por: Luo, Xinxin, et al.
Publicado: (2023) -
Association between 25 Hydroxyvitamin D Concentrations and the Risk of COVID-19: A Mendelian Randomization Study
por: LIU, Di, et al.
Publicado: (2021) -
Association of 25-hydroxyvitamin D with cardiometabolic risk factors and metabolic syndrome: a mendelian randomization study
por: Chen, Chi, et al.
Publicado: (2019)